ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos6.45 B5.11 B5.89 B5.92 B6.75 B23.68 BInvestigación y desarrollo5.3 B3.23 B3.52 B3.67 B4.25 B14.66 BBeneficio operativo-1.14 B5.06 B5.14 B5.95 B677 M16.82 BTotal de ingresos no operativos442 M7.65 B153 M705 M-246 M8.27 BGastos por intereses, netos de intereses capitalizados137 M204 M308 M245 M214 M971 MIngresos no operativos, una vez deducidos los gastos por intereses144 M128 M-48 M-18 M23 M85 MIngresos/gastos extraordinarios161 M7.32 B-107 M478 M-483 M7.21 BBeneficio antes de impuestos3.89 B13.63 B6.49 B7.49 B4.97 B32.58 BParticipación en los beneficios——————Impuestos456 M2.63 B954 M2.34 B-150 M5.78 BParticipación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas3.43 B11 B5.54 B5.15 B5.12 B26.8 BOperaciones suspendidas0———0—Beneficio neto3.43 B11 B5.54 B5.15 B5.12 B26.8 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas3.43 B11 B5.54 B5.15 B5.12 B26.8 BBeneficio básico por acción1.424.572.32.142.1211.13Beneficio por acción diluido1.414.542.292.122.0811.03Número medio de acciones ordinarias2.41 B2.41 B2.41 B2.41 B2.41 B9.63 BAcciones diluidas2.43 B2.42 B2.42 B2.43 B2.43 B9.7 BEBITDA755 M6.83 B7.08 B7.73 B2.69 B24.32 BEBIT-1.14 B5.06 B5.14 B5.95 B677 M16.82 BCosto de los ingresos7.13 B7.36 B7.63 B7.3 B7.97 B30.26 BOtros costes de producción——————Amortización y depreciación (flujo de caja)1.9 B1.77 B1.94 B1.78 B2.01 B7.5 B
Johnson & Johnson
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.